Periodontitis is characterized by an immuno-inflammatory host-mediated destruction of bone and connective tissues that support the teeth

Journal of Periodontology

Volumn 85, Issue 4, 2014, Pages 509-511

  Van Dyke, Thomas E ^a  

^a Department of Applied Oral Sciences Center for Periodontology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID;

ALVEOLAR BONE LOSS; BACTERIA; CONNECTIVE TISSUE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PERIODONTITIS;

ALVEOLAR BONE LOSS; ANTI-INFLAMMATORY AGENTS; BACTERIA; CONNECTIVE TISSUE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; PERIODONTITIS;

EID: 84897371730     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2014.130701     Document Type: Note

References (16)

1. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249.
2. Cianciola LJ, Genco RJ, Patters MR, McKenna J, van Oss CJ. Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature 1977;265: 445-447.
3. Lavine WS, Maderazo EG, Stolman J, et al. Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res 1979;14:10-19.
4. Van Dyke TE, Horoszewicz HU, Cianciola LJ, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun 1980;27:124-132.
5. Ivanyi L, Wilton JM, Lehner T. Cell-mediated immunity in periodontal disease; cytotoxicity, migration inhibition and lymphocyte transformation studies. Immunology 1972;22:141-145.
6. Patters MR, Genco RJ, Reed MJ, Mashimo PA. Blastogenic response of human lymphocytes to oral bacterial antigens: Comparison of individuals with periodontal disease to normal and edentulous subjects. Infect Immun 1976;14:1213-1220.
7. Lang NP, Smith FN. Lymphocyte blastogenesis to plaque antigens in human periodontal disease. I. Populations of varying severity of disease. J Periodontal Res 1977;12:298-309.
8. Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 2006;40:144-163.
9. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26:230-242.
10. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998;12:12-26.
11. Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, Shapira L. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappa B. Infect Immun 1999;67:5573-5578.
12. Howell TH,Williams RC.Non-steroidal anti-inflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med 1993;4:177-196.
13. Offenbacher S, Williams RC, Jeffcoat MK, et al. Effects of NSAIDs on beagle crevicular cyclooxygenase metabolites and periodontal bone loss. J Periodontal Res 1992;27:207-213.
14. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-361.
15. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: State of the art, definitions and terms. FASEB J 2007;21:325-332.
16. Omori K, Ohira T, Uchida Y, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292-301.